Annual Total Liabilities
$48.61 M
+$5.26 M+12.14%
March 31, 2024
Summary
- As of February 12, 2025, IMVT annual total liabilities is $48.61 million, with the most recent change of +$5.26 million (+12.14%) on March 31, 2024.
- During the last 3 years, IMVT annual total liabilities has risen by +$27.60 million (+131.37%).
- IMVT annual total liabilities is now at all-time high.
Performance
IMVT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$68.31 M
+$1.66 M+2.49%
December 31, 2024
Summary
- As of February 12, 2025, IMVT quarterly total liabilities is $68.31 million, with the most recent change of +$1.66 million (+2.49%) on December 31, 2024.
- Over the past year, IMVT quarterly total liabilities has increased by +$36.21 million (+112.81%).
- IMVT quarterly total liabilities is now at all-time high.
Performance
IMVT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
IMVT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.1% | +112.8% |
| 3 y3 years | +131.4% | +79.6% |
| 5 y5 years | +217.3% | +362.9% |
IMVT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +131.4% | at high | +208.2% |
| 5 y | 5-year | at high | >+9999.0% | at high | +362.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Immunovant Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $68.31 M(+2.5%) |
| Sep 2024 | - | $66.65 M(+48.1%) |
| Jun 2024 | - | $45.02 M(-7.4%) |
| Mar 2024 | $48.61 M(+12.1%) | $48.61 M(+51.4%) |
| Dec 2023 | - | $32.10 M(-20.3%) |
| Sep 2023 | - | $40.26 M(-21.6%) |
| Jun 2023 | - | $51.36 M(+18.5%) |
| Mar 2023 | $43.34 M(-5.2%) | $43.34 M(+4.3%) |
| Dec 2022 | - | $41.56 M(+28.3%) |
| Sep 2022 | - | $32.40 M(+46.2%) |
| Jun 2022 | - | $22.16 M(-51.5%) |
| Mar 2022 | $45.74 M | $45.74 M(+20.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | - | $38.03 M(+25.4%) |
| Sep 2021 | - | $30.34 M(+34.9%) |
| Jun 2021 | - | $22.50 M(+7.1%) |
| Mar 2021 | $21.01 M(+37.2%) | $21.01 M(+11.3%) |
| Dec 2020 | - | $18.88 M(+21.9%) |
| Sep 2020 | - | $15.49 M(-31.2%) |
| Jun 2020 | - | $22.52 M(+47.0%) |
| Mar 2020 | $15.32 M(+3926.8%) | $15.32 M(+3.8%) |
| Dec 2019 | - | $14.76 M(+238.3%) |
| Sep 2019 | - | $4.36 M(+6.0%) |
| Jun 2019 | - | $4.12 M(+1270.2%) |
| Mar 2019 | - | $300.40 K |
| Dec 2018 | $380.40 K | - |
FAQ
- What is Immunovant annual total liabilities?
- What is the all time high annual total liabilities for Immunovant?
- What is Immunovant annual total liabilities year-on-year change?
- What is Immunovant quarterly total liabilities?
- What is the all time high quarterly total liabilities for Immunovant?
- What is Immunovant quarterly total liabilities year-on-year change?
What is Immunovant annual total liabilities?
The current annual total liabilities of IMVT is $48.61 M
What is the all time high annual total liabilities for Immunovant?
Immunovant all-time high annual total liabilities is $48.61 M
What is Immunovant annual total liabilities year-on-year change?
Over the past year, IMVT annual total liabilities has changed by +$5.26 M (+12.14%)
What is Immunovant quarterly total liabilities?
The current quarterly total liabilities of IMVT is $68.31 M
What is the all time high quarterly total liabilities for Immunovant?
Immunovant all-time high quarterly total liabilities is $68.31 M
What is Immunovant quarterly total liabilities year-on-year change?
Over the past year, IMVT quarterly total liabilities has changed by +$36.21 M (+112.81%)